ELVN as of Oct 31 · 13:57 ET

ELVNNasdaqPharmaceutical Preparations

Enliven Therapeutics, Inc. · Brief

Next report

11 days

Nov 11 · after closeest.Q3 FY26

Earnings

Expected move

Inputs

±6.0%implied · report alone

41.6146.89

straddle ±10.7%

spot 44.25exp Nov 20ATM strike 45ATM straddle 5.57IV 65%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

0 of 8≥ implied

avg implied: ±16.9%
avg realized: ±3.0%

Nov 13 '24±16.6%▼−3.41%×0.21

Mar 13 '25±20.8%▲+2.22%×0.11

May 14 '25±19.0%▼−10.41%×0.55

Aug 13 '25±21.6%▼−1.08%×0.05

Q3 FY25±19.4%▼−0.15%×0.01

Q1 FY26±15.4%▲+4.28%×0.28

May 7 '26±11.1%▲+1.14%×0.10

Q2 FY26±11.2%▲+0.95%×0.08

quarterimplied−25%0+25%realized×

Q2 FY26±11.2%▲+0.95%×0.08

May '26±11.1%▲+1.14%×0.10

Q1 FY26±15.4%▲+4.28%×0.28

Q3 FY25±19.4%▼−0.15%×0.01

Aug '25±21.6%▼−1.08%×0.05

May '25±19.0%▼−10.41%×0.55

2 older reports

Mar '25±20.8%▲+2.22%×0.11

Nov '24±16.6%▼−3.41%×0.21

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

5disclosed supplier and customer ties in SEC filingsSEC filings

212managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

8 of 8recent reports where the move came in under the options-implied rangeEarnings history

3tracked funds holding ELVNN-PORT · Aug 31 '26

AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ELVN report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 28impliedImplied move: ±8.8% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.